Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage

被引:14
|
作者
Liao, Pei-Ju [1 ]
Lin, Tzu-Yu [2 ]
Wang, Tzu-Ching [3 ]
Ting, Ming-Kuo [5 ]
Wu, I-Wen [4 ,6 ]
Huang, Hsin-Tsung [3 ]
Wang, Fu-Chung [3 ]
Chang, Huan-Cheng [7 ,8 ]
Hsu, Kuang-Hung [2 ,8 ]
机构
[1] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan
[2] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan
[3] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan
[4] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Keelung, Taiwan
[6] Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Keelung, Taiwan
[7] Taiwan Landseed Hosp, Dept Med, Div Nephrol, New Taipei, Taiwan
[8] Chang Gung Univ, Dept Hlth Care Management, Taoyuan, Taiwan
关键词
HEALTH-CARE; COST-EFFECTIVENESS; RENAL-DISEASE; IMPACT; OUTCOMES; MANAGEMENT; HYPERTENSION; PREVALENCE; INHIBITORS; DIALYSIS;
D O I
10.1097/MD.0000000000003282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a major health problem worldwide because of the aging population and lifestyle changes. One of the important etiologies of CKD is diabetes mellitus (DM). The long-term effects of pay-for-performance (P4P) on disease progression have not been thoroughly examined. This study is a retrospective population-based patient cohort design to examine the continuous effects of diabetes and CKD P4P interventions. This study used the health insurance claims database to conduct a longitudinal analysis. A total of 32,084 early CKD patients with diabetes were extracted from the outpatient claims database from January 2011 to December 2012, and the follow-up period was extended to August 2014. A 4-group matching design, including both diabetes and early CKD P4P interventions, with only diabetes P4P intervention, with only early CKD P4P intervention, and without any P4P interventions, was performed according to their descending intensity. The primary outcome of this study was all-cause mortality and the causes of death. The statistical methods included a Chi-squared test, ANOVA, and multi-variable Cox regression models. A dose-response relationship between the intervention groups and all-cause mortality was observed as follows: comparing to both diabetes and early CKD P4P interventions (reference), hazard ratio (HR) was 1.22 (95% confidence interval [CI], 1.00-1.50) for patients with only a diabetes P4P intervention; HR was 2.00 (95% CI, 1.66-2.42) for patients with only an early CKD P4P intervention; and HR was 2.42 (95% CI, 2.02-2.91) for patients without any P4P interventions. The leading cause of death of the total diabetic nephropathy patient cohort was infectious diseases (34.32%) followed by cardiovascular diseases (17.12%), acute renal failure (1.50%), and malignant neoplasm of liver (1.40%). Because the earlier interventions have lasting long-term effects on the patient's prognosis regardless of disease course, an integrated early intervention plan is suggested in future care plan designs. The mechanisms regarding the effects of P4P intervention, such as health education on diet control, continuity of care, and practice guidelines and adherence, are the primary components of disease management programs.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Effects of Long-Term Statin Therapy in Coronary Artery Disease Patients with or without Chronic Kidney Disease
    Huang, Huiling
    Zeng, Chunmei
    Ma, Yuedong
    Chen, Yili
    Chen, Cong
    Liu, Chen
    Dong, Yugang
    [J]. DISEASE MARKERS, 2015, 2015
  • [22] The Effect of Nutritional Interventions on Long-Term Patient Survival in Advanced Chronic Kidney Disease
    Perez-Torres, Almudena
    Gonzalez Garcia, M. Elena
    Ossorio-Gonzalez, Marta
    Alvarez Garcia, Laura
    Bajo, M. Auxiliadora
    del Peso, Gloria
    Castillo Plaza, Ana
    Selgas, Rafael
    [J]. NUTRIENTS, 2021, 13 (02) : 1 - 11
  • [23] LONG-TERM EFFECTS OF THE NEW NORDIC RENAL DIET ON PHOSPHOROUS HOMEOSTASIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 3 AND 4
    Hansen, Nikita Misella
    Kamper, Anne Lise
    Rix, Marianne
    Feldt-Rasmussen, Bo
    Pareek, Manan
    Sorensen, Mads Vaarby
    Berg, Peder
    Leipziger, Jens
    Astrup, Arne
    Salomo, Louise
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I656 - I657
  • [24] Regarding "Perioperative and long-term impact of chronic kidney disease on carotid artery interventions"
    Bissacco, Daniele
    Settembrini, Piergiorgio
    [J]. JOURNAL OF VASCULAR SURGERY, 2017, 65 (05) : 1549 - 1550
  • [25] Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease
    Nakano, Yujiro
    Murakami, Masanori
    Hara, Kazunari
    Fukuda, Tatsuya
    Horino, Masato
    Takeuchi, Akira
    Niitsu, Yoshihiro
    Shiba, Kumiko
    Tsujimoto, Kazutaka
    Komiya, Chikara
    Yokoyama, Minato
    Ikeda, Kenji
    Yoshimoto, Takanobu
    Fujii, Yasuhisa
    Yamada, Tetsuya
    [J]. CLINICAL ENDOCRINOLOGY, 2023, 98 (03) : 323 - 331
  • [26] Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
    Yang, Chen-Ta
    Kor, Chew-Teng
    Hsieh, Yao-Peng
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (11)
  • [27] Long-term effects of patiromer for hyperkalaemia treatment in patients with HFrEF and diabetic nephropathy on RAASi
    Pitt, B.
    Garza, D.
    Zawadzki, R.
    Romero, A.
    Conrad, A.
    Lainscak, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 55 - 55
  • [28] The decrease of Klotho expression via hypoxic states in kidney was associated with hypercalciuria in diabetic nephropathy with early chronic kidney disease stage
    Nakatani, Kimihiko
    Asai, Osamu
    Sakan, Hirokazu
    Tanaka, Tomohiro
    Imura, Akihiro
    Nabeshima, Yo-ichi
    Saito, Yoshihiko
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S371 - S371
  • [29] PREVALENCE OF ANEMIA IN EARLY STAGE OF DIABETIC NEPHROPATHY (CHRONIC KIDNEY DISEASE STAGE II) AND ITS IMPACT ON THE PROGRESSION OF RENAL FUNCTION
    Gjata, M.
    Nelaj, E.
    Sadiku, E.
    Collaku, E.
    Tase, M.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E288 - E288
  • [30] LONG-TERM GLYCEMIC CONTROL AND THE RATE OF PROGRESSION OF EARLY DIABETIC KIDNEY-DISEASE
    GILBERT, RE
    TSALAMANDRIS, C
    BACH, LA
    PANAGIOTOPOULOS, S
    OBRIEN, RC
    ALLEN, TJ
    GOODALL, I
    YOUNG, V
    SEEMAN, E
    MURRAY, RML
    COOPER, ME
    JERUMS, G
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (04) : 855 - 859